Celldex Therapeutics Inc. (CLDX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Celldex Therapeutics Inc.

    NASDAQ: CLDX · Real-Time Price · USD
    26.41
    0.56 (2.17%)
    At close: Oct 03, 2025, 3:59 PM
    26.55
    0.53%
    After-hours: Oct 03, 2025, 04:27 PM EDT

    Celldex Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 28.36M 34.81M 29.43M 39.14M
    Short-Term Investments
    		 696.92M 388.78M 275.52M 369.11M
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 9.75M 107K n/a n/a
    Receivables
    		 700K 2.63M 347K 172K
    Inventory
    		 n/a n/a -347K -172K
    Other Current Assets
    		 21.18M 5.47M 12.74M 172K
    Total Current Assets
    		 747.16M 431.69M 317.69M 410.84M
    Property-Plant & Equipment
    		 8.24M 6.64M 3.75M 3.55M
    Goodwill & Intangibles
    		 27.19M 27.19M 31.3M 30.26M
    Total Long-Term Assets
    		 45.18M 33.93M 35.04M 33.81M
    Total Assets
    		 792.34M 465.63M 352.74M 444.65M
    Account Payables
    		 3.27M 3.49M 3.34M 1.23M
    Deferred Revenue
    		 n/a n/a n/a 12M
    Short-Term Debt
    		 1.45M 1.61M 1.45M 1.75M
    Other Current Liabilities
    		 33.33M 2.37M 4.85M -12.19M
    Total Current Liabilities
    		 39.5M 31.13M 18.61M 16.53M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 3.47M 4.4M 5.33M 7.35M
    Total Long-Term Liabilities
    		 5.83M 5.33M 7.92M 8.65M
    Total Liabilities
    		 45.34M 36.46M 26.53M 25.18M
    Total Debt
    		 3.81M 2.54M 4.03M 3.04M
    Book Value
    		 747M 429.17M 326.2M 419.48M
    Book Value Per Share
    		 11.60 8.86 6.96 9.78
    Common Stock
    		 66K 56K 47K 47K
    Retained Earnings
    		 -1.56B -1.4B -1.26B -1.14B
    Comprehensive Income
    		 3.31M 3.31M 1.26M 1.89M
    Shareholders Equity
    		 747M 429.17M 326.2M 419.48M
    Total Investments
    		 696.92M 388.78M 275.52M 369.11M

    Add to Watchlist